TYP Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Exopharm Ltd

Watchlist Manager

Watchlist

Price: 0.034 AUD Market Closed

Market Cap: AU$47.3m

	Exopharm Ltd ASX:TYP	AU
D	Digital Chosun KOSDAQ:033130	KR

Profitability Summary

Exopharm Ltd's profitability score is 5/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-345%

Negative 3Y Average Operating Margin

-345%

Declining Operating Margin

-199% > -345%

Negative Net Margin

-358%

Negative 3Y Average Net Margin

-358%

Declining Net Margin

-209% > -358%

Negative Free Cash Flow Margin

-118%

Negative 3Y Average Free Cash Flow Margin

-118%

Free Cash Flow Margin is Increasing

-121% > -118%

Negative ROE

-122%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-161%

Declining ROIC

-111% > -161%

View All

Hide

Collapse

5 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-345%

Negative 3Y Average Operating Margin

-345%

Declining Operating Margin

-199% > -345%

Negative Net Margin

-358%

Negative 3Y Average Net Margin

-358%